Acrivon Therapeutics ACRV Cash Flow Statement (2021-2026)

NASDAQ ACRV
$2.08 +0.02 (+0.97%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Acrivon Therapeutics Quarterly Cash Flow Statement

Periods 20 quarters
Latest Jun 2026

Acrivon Therapeutics reported cash from operations of -$14.86M and free cash flow of -$14.95M for the quarter ended Jun 2026, up 10.5% year over year. This cash flow statement covers 20 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -2.44M-4.34M-7.21M-5.92M-9.20M-8.93M-14.39M-15.52M-16.14M-21.05M-17.67M-21.44M-25.14M-24.95M-21.66M-22.65M-19.69M-20.12M-19.90M-18.67M
Depreciation and Depletion 0.01M0.01M0.04M0.10M0.10M0.16M0.12M0.10M0.10M0.14M0.22M0.20M0.30M0.30M0.31M0.30M0.30M0.40M0.40M0.40M
Share-based Compensation 0.30M0.04M0.23M0.27M1.65M2.65M2.69M3.23M3.06M3.34M3.57M3.67M3.71M3.79M3.93M3.91M3.09M2.18M2.21M
Cash from Operations -3.63M-8.42M-5.82M-6.52M-9.35M-11.36M-9.11M-9.81M-12.37M-17.08M-13.90M-17.32M-17.36M-19.54M-16.61M-12.28M-15.24M-20.54M-14.86M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization 0.01M0.01M0.04M0.10M0.10M0.16M0.12M0.10M0.10M0.14M0.22M0.20M0.30M0.30M0.31M0.30M0.30M0.40M0.40M0.40M
Change in Working Capital
Change in Account Payables 0.30M-0.10M0.54M0.03M-0.73M0.47M-0.11M0.08M3.17M-2.27M-0.94M-0.14M-0.23M2.82M-2.55M-0.01M1.28M-1.20M-0.21M
Change in Accured Expenses 1.00M-0.33M0.74M0.98M1.53M-1.32M1.43M2.02M1.04M-1.48M2.87M3.46M3.18M-7.00M2.15M1.97M-0.48M-3.38M0.71M
Other Working Capital Changes 1.07M0.88M1.61M-1.45M2.50M-0.59M-1.42M0.07M-0.17M-0.20M-0.22M-0.28M-0.35M-0.47M-0.70M0.22M0.01M-0.38M-0.21M
Investing Activities
Capital Expenditures 0.14M0.41M1.07M0.43M0.25M0.03M0.11M1.15M0.81M0.14M0.99M0.83M0.06M0.49M0.90M0.22M0.01M0.09M
Cash from Investing Activities -0.14M-0.41M-1.07M-45.12M-95.07M9.33M19.34M1.52M20.54M5.85M-88.04M16.01M14.41M19.21M19.45M5.91M21.52M13.13M14.95M
Financing Activities
Other financing activities 0.17M0.51M1.20M0.65M0.34M0.10M0.12M0.19M0.03M0.03M
Change in Capital Stock
Net Equity Issued and Repurchased 99.78M0.08M0.32M0.08M69.92M0.00M7.30M
Misc.
Cash from Financing Activities 99.75M-0.14M101.86M0.08M-2.01M-0.17M123.35M-1.50M-0.65M-0.34M-0.10M-0.12M-0.19M-0.03M7.27M
Change in Cash 95.99M-8.83M-6.91M-51.78M-2.56M-2.03M10.61M-8.21M6.16M-11.40M21.40M-2.82M-3.60M-0.66M2.74M-6.49M6.09M-7.44M7.35M
Free Cash Flow -3.76M-8.83M-6.90M-6.95M-9.61M-11.38M-9.22M-9.81M-13.52M-17.90M-14.04M-18.31M-18.19M-19.59M-17.10M-13.18M-15.46M-20.55M-14.95M
Net Cash Flow 95.99M-8.83M-6.90M-51.78M-2.56M-2.03M10.23M-8.21M6.16M-11.40M21.40M-2.82M-3.60M-0.66M2.74M-6.49M6.09M-7.44M7.35M

Acrivon Therapeutics Cash Flow Statement API

Pull Acrivon Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACRV&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY